The Company

Caring deeply. Changing lives.

Biogen is one of the world’s leading biotechnology companies, with a focus on developing therapies for neurodegenerative, hematologic and autoimmune disorders.

We measure success by our impact on the patients we serve

Every day we ask ourselves one question: Are we truly making a difference in people’s lives?

Leaders with a shared passion

Our leaders share a passion for innovation and visionary science.

Michel Vounatsos
Chief Executive Officer
Susan
Alexander
Executive Vice President, Chief Legal Officer and Corporate Secretary
Paul
Clancy
Executive Vice President, Chief Financial Officer
John
Cox
Chief Executive Officer, Bioverativ Former Executive VP, Pharmaceutical Operations and Technology, Biogen
Kenneth
DiPietro
Executive Vice President Human Resources
Michael
Ehlers, M.D., Ph.D.
Executive Vice President, Head of R&D
Adriana
Karaboutis
Executive Vice President Technology and Business Solutions
Paul
McKenzie
Executive Vice President Pharmaceutical Operations & Technology
Alfred
Sandrock, Jr., M.D., Ph.D.
Executive Vice President, Head of Development and Worldwide Medical and Chief Medical Officer

Nearly four decades of visionary science

One of the world’s oldest independent biotech company began when a group of scientists came together to pursue a new approach to drug discovery.

A global network makes a world of difference

 

Our global manufacturing and supply network works to provide innovative, quality medicines wherever and whenever they are needed.

Learn more about manufacturing